RU96120415A - ANTITASCULAR COMPOSITION CONTAINING ANTITASCULAR AGENT AND BENZIDAMINE - Google Patents
ANTITASCULAR COMPOSITION CONTAINING ANTITASCULAR AGENT AND BENZIDAMINEInfo
- Publication number
- RU96120415A RU96120415A RU96120415/14A RU96120415A RU96120415A RU 96120415 A RU96120415 A RU 96120415A RU 96120415/14 A RU96120415/14 A RU 96120415/14A RU 96120415 A RU96120415 A RU 96120415A RU 96120415 A RU96120415 A RU 96120415A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutically acceptable
- composition according
- acceptable salt
- benzidamine
- dextromethorphan
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 8
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N Benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 title claims 4
- 229960000333 benzydamine Drugs 0.000 title claims 4
- 150000003839 salts Chemical class 0.000 claims 7
- 239000011780 sodium chloride Substances 0.000 claims 7
- 229960001985 Dextromethorphan Drugs 0.000 claims 4
- MKXZASYAUGDDCJ-SZMVWBNQSA-N Dextromethorphan Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 claims 4
- 239000003434 antitussive agent Substances 0.000 claims 3
- OROGSEYTTFOCAN-DNJOTXNNSA-N Codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 239000007937 lozenge Substances 0.000 claims 2
- RBOXVHNMENFORY-DNJOTXNNSA-N Dihydrocodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC RBOXVHNMENFORY-DNJOTXNNSA-N 0.000 claims 1
- 229960001056 Dimemorfan Drugs 0.000 claims 1
- KBEZZLAAKIIPFK-NJAFHUGGSA-N Dimemorfan Chemical compound C1C2=CC=C(C)C=C2[C@@]23CCN(C)[C@@H]1[C@H]2CCCC3 KBEZZLAAKIIPFK-NJAFHUGGSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N Hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 claims 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N Hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 claims 1
- 210000004400 Mucous Membrane Anatomy 0.000 claims 1
- 229960004708 Noscapine Drugs 0.000 claims 1
- AKNNEGZIBPJZJG-MSOLQXFVSA-N Noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 claims 1
- CFJMRBQWBDQYMK-UHFFFAOYSA-N Pentoxyverine Chemical compound C=1C=CC=CC=1C1(C(=O)OCCOCCN(CC)CC)CCCC1 CFJMRBQWBDQYMK-UHFFFAOYSA-N 0.000 claims 1
- 229960003436 Pentoxyverine Drugs 0.000 claims 1
- VZPXFHVJUUSVLH-VNJAQMQMSA-N [(2R,3S)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21.C([C@@](OC(=O)CC)([C@@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VZPXFHVJUUSVLH-VNJAQMQMSA-N 0.000 claims 1
- 230000000954 anitussive Effects 0.000 claims 1
- 229940096338 carbetapentane Drugs 0.000 claims 1
- 239000007910 chewable tablet Substances 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 229960004126 codeine Drugs 0.000 claims 1
- 229960000920 dihydrocodeine Drugs 0.000 claims 1
- GVLGAFRNYJVHBC-UHFFFAOYSA-N hydrate;hydrobromide Chemical compound O.Br GVLGAFRNYJVHBC-UHFFFAOYSA-N 0.000 claims 1
- 229960000240 hydrocodone Drugs 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- 229960001410 hydromorphone Drugs 0.000 claims 1
- 229930014621 narcotine Natural products 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Claims (8)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI940362A IT1274026B (en) | 1994-03-01 | 1994-03-01 | ANTITOSSE COMPOSITION |
ITMI94A000362 | 1994-03-01 | ||
PCT/EP1995/000658 WO1995023602A1 (en) | 1994-03-01 | 1995-02-22 | Antitussive composition containing an antitussive and benzydamine |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96120415A true RU96120415A (en) | 1998-12-27 |
RU2143901C1 RU2143901C1 (en) | 2000-01-10 |
Family
ID=11368015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96120415A RU2143901C1 (en) | 1994-03-01 | 1995-02-22 | Antibechic composition containing antibechic agent and benzidamine |
Country Status (27)
Country | Link |
---|---|
US (1) | US5932589A (en) |
EP (1) | EP0748222B1 (en) |
JP (1) | JP3348858B2 (en) |
KR (1) | KR970701047A (en) |
CN (1) | CN1088358C (en) |
AT (1) | ATE195074T1 (en) |
AU (1) | AU681257B2 (en) |
BR (1) | BR9506956A (en) |
CA (1) | CA2184594C (en) |
CZ (1) | CZ284798B6 (en) |
DE (1) | DE69518229T2 (en) |
DK (1) | DK0748222T3 (en) |
ES (1) | ES2149969T3 (en) |
FI (1) | FI963394A (en) |
GR (1) | GR3034665T3 (en) |
HU (1) | HUT75937A (en) |
IT (1) | IT1274026B (en) |
NO (1) | NO309965B1 (en) |
NZ (1) | NZ281230A (en) |
PL (1) | PL178608B1 (en) |
PT (1) | PT748222E (en) |
RO (1) | RO117147B1 (en) |
RU (1) | RU2143901C1 (en) |
SK (1) | SK282567B6 (en) |
UA (1) | UA37278C2 (en) |
WO (1) | WO1995023602A1 (en) |
ZA (1) | ZA951588B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124282A (en) * | 1997-05-22 | 2000-09-26 | Sellers; Edward M. | Drug formulations |
PT1041987E (en) * | 1997-12-22 | 2006-07-31 | Euro Celtique Sa | PHARMACEUTICAL FORM OF ORAL DOSAGE, UNDERSTANDING A COMBINATION OF AN AGRONIST OF OPIOIDE AND NALTREXONE |
US7138133B2 (en) | 2001-10-10 | 2006-11-21 | The Procter & Gamble Company | Orally administered liquid compositions |
AU2003219348A1 (en) * | 2002-04-22 | 2003-11-03 | Adcock Ingram Intellectual Property (Proprietary) Limited | Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
DE602005020359D1 (en) * | 2005-01-14 | 2010-05-12 | Camurus Ab | TOPICAL BIOADHESIVE FORMULATIONS |
CA2594710C (en) * | 2005-01-14 | 2011-01-25 | Camurus Ab | Topical bioadhesive formulations |
CN101219140B (en) * | 2007-12-24 | 2011-06-01 | 重庆市莱美药物技术有限公司 | Benzydamine Hcl soluble tablet and method for preparing the same |
ES2554332T3 (en) | 2009-07-08 | 2015-12-18 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Use of benzydamine in the treatment of p40 dependent diseases |
KR102290178B1 (en) * | 2013-03-13 | 2021-08-18 | 트리스 파마 인코포레이티드 | Benzonatate modified release solid tablets and capsules |
EP3256459B1 (en) * | 2015-02-09 | 2022-07-13 | Cellixbio Private Limited | Compositions and methods for the treatment of mucositis |
US11214544B2 (en) | 2017-04-14 | 2022-01-04 | Kempharm, Inc. | Dextrorphan prodrugs and processes for making and using them |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0555411A1 (en) * | 1990-10-31 | 1993-08-18 | The Procter & Gamble Company | Dextromethorphan antitussive compositions |
US5196436A (en) * | 1990-10-31 | 1993-03-23 | The Procter & Gamble Company | Dextromethorphan antitussive compositions |
-
1994
- 1994-03-01 IT ITMI940362A patent/IT1274026B/en active IP Right Grant
-
1995
- 1995-02-22 CN CN95191917A patent/CN1088358C/en not_active Expired - Fee Related
- 1995-02-22 US US08/700,362 patent/US5932589A/en not_active Expired - Fee Related
- 1995-02-22 AT AT95909772T patent/ATE195074T1/en not_active IP Right Cessation
- 1995-02-22 PL PL95316079A patent/PL178608B1/en not_active IP Right Cessation
- 1995-02-22 RO RO96-01736A patent/RO117147B1/en unknown
- 1995-02-22 WO PCT/EP1995/000658 patent/WO1995023602A1/en active IP Right Grant
- 1995-02-22 RU RU96120415A patent/RU2143901C1/en not_active IP Right Cessation
- 1995-02-22 UA UA96093730A patent/UA37278C2/en unknown
- 1995-02-22 JP JP52267395A patent/JP3348858B2/en not_active Expired - Fee Related
- 1995-02-22 CZ CZ962532A patent/CZ284798B6/en not_active IP Right Cessation
- 1995-02-22 CA CA002184594A patent/CA2184594C/en not_active Expired - Fee Related
- 1995-02-22 EP EP95909772A patent/EP0748222B1/en not_active Expired - Lifetime
- 1995-02-22 AU AU18116/95A patent/AU681257B2/en not_active Ceased
- 1995-02-22 PT PT95909772T patent/PT748222E/en unknown
- 1995-02-22 DE DE69518229T patent/DE69518229T2/en not_active Expired - Fee Related
- 1995-02-22 SK SK1085-96A patent/SK282567B6/en unknown
- 1995-02-22 BR BR9506956A patent/BR9506956A/en not_active IP Right Cessation
- 1995-02-22 DK DK95909772T patent/DK0748222T3/en active
- 1995-02-22 ES ES95909772T patent/ES2149969T3/en not_active Expired - Lifetime
- 1995-02-22 KR KR1019960704800A patent/KR970701047A/en not_active Application Discontinuation
- 1995-02-22 HU HU9602390A patent/HUT75937A/en unknown
- 1995-02-22 NZ NZ281230A patent/NZ281230A/en not_active IP Right Cessation
- 1995-02-24 ZA ZA951588A patent/ZA951588B/en unknown
-
1996
- 1996-08-30 FI FI963394A patent/FI963394A/en not_active Application Discontinuation
- 1996-08-30 NO NO963634A patent/NO309965B1/en not_active IP Right Cessation
-
2000
- 2000-10-23 GR GR20000402355T patent/GR3034665T3/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5869498A (en) | Pain alleviating drug composition and method for alleviating pain | |
US5196436A (en) | Dextromethorphan antitussive compositions | |
KR101326206B1 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
ES2729679T3 (en) | Morphinan derivatives for the treatment of drug overdose | |
IL149496A (en) | Pharmaceutical combinations and their use in treating gastrointestinal disorders | |
RU96120415A (en) | ANTITASCULAR COMPOSITION CONTAINING ANTITASCULAR AGENT AND BENZIDAMINE | |
US5622980A (en) | Oral compositions of H2-antagonists | |
KR970701047A (en) | ANTITUSSIVE COMPOSITION CONTAINING AN ANTITUS SIVE AND BENZYDAMINE | |
JP2575569B2 (en) | Use of glycine / NMDA receptor ligand for the treatment of drug dependence and withdrawal symptoms | |
WO1991018606A3 (en) | Orally active nonaddicting analgesics | |
US20050053656A1 (en) | Compositions and methods for treating pain | |
CA2129676C (en) | Dextromethorphan antitussive compositions | |
US3755586A (en) | Anti tussive compositions containing piperidine derivatives | |
RU2003135201A (en) | APPLICATION OF THE NALTREXONE OPIOID ANTAGONIST FOR THE PREVENTION AND CONTROL OF ADVERSE EFFECTS CAUSED BY OPIOIDS | |
WO1994020074A1 (en) | Adsorbate compositions | |
US20070248667A1 (en) | Tannate Compositions and Methods of Use | |
MXPA96003747A (en) | Antitus composition | |
MXPA96006041A (en) | Dosage form of rapida disoluc |